Current Ratio of Oruka Therapeutics, Inc. from 31 Mar 2012 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Oruka Therapeutics, Inc. quarterly Current Ratio in x history and change rate from 31 Mar 2012 to 31 Dec 2025.
- Oruka Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 22.99x, a 9.3% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Oruka Therapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 22.99x | -2.37x | -9.3% | 31 Dec 2025 |
| Q3 2025 | 24.48x | +0.28x | +1.2% | 30 Sep 2025 |
| Q2 2025 | 26.84x | -5.96x | -18% | 30 Jun 2025 |
| Q1 2025 | 26.67x | -5.31x | -17% | 31 Mar 2025 |
| Q4 2024 | 25.35x | -9.99x | -28% | 31 Dec 2024 |
| Q3 2024 | 24.2x | -8.66x | -26% | 30 Sep 2024 |
| Q2 2024 | 32.8x | +4.21x | +15% | 30 Jun 2024 |
| Q1 2024 | 31.98x | +7.26x | +29% | 31 Mar 2024 |
| Q4 2023 | 35.34x | +13.77x | +64% | 31 Dec 2023 |
| Q3 2023 | 32.86x | +14.88x | +83% | 30 Sep 2023 |
| Q2 2023 | 28.58x | +11.2x | +64% | 30 Jun 2023 |
| Q1 2023 | 24.72x | +7.2x | +41% | 31 Mar 2023 |
| Q4 2022 | 21.57x | +2.89x | +15% | 31 Dec 2022 |
| Q3 2022 | 17.98x | -0.36x | -2% | 30 Sep 2022 |
| Q2 2022 | 17.39x | -2.9x | -14% | 30 Jun 2022 |
| Q1 2022 | 17.52x | -2.21x | -11% | 31 Mar 2022 |
| Q4 2021 | 18.68x | +2.59x | +16% | 31 Dec 2021 |
| Q3 2021 | 18.34x | +2.26x | +14% | 30 Sep 2021 |
| Q2 2021 | 20.29x | +12.1x | +148% | 30 Jun 2021 |
| Q1 2021 | 19.73x | +11.59x | +142% | 31 Mar 2021 |
| Q4 2020 | 16.09x | +7.94x | +97% | 31 Dec 2020 |
| Q3 2020 | 16.08x | +8.06x | +101% | 30 Sep 2020 |
| Q2 2020 | 8.19x | +0.2x | +2.5% | 30 Jun 2020 |
| Q1 2020 | 8.15x | -0.04x | -0.43% | 31 Mar 2020 |
| Q4 2019 | 8.16x | -0.17x | -2.1% | 31 Dec 2019 |
| Q3 2019 | 8.02x | +0.57x | +7.6% | 30 Sep 2019 |
| Q2 2019 | 7.99x | +1.03x | +15% | 30 Jun 2019 |
| Q1 2019 | 8.18x | +1.62x | +25% | 31 Mar 2019 |
| Q4 2018 | 8.33x | +1.58x | +23% | 31 Dec 2018 |
| Q3 2018 | 7.45x | +0x | +0.04% | 30 Sep 2018 |
| Q2 2018 | 6.95x | -1.57x | -18% | 30 Jun 2018 |
| Q1 2018 | 6.56x | -3.92x | -37% | 31 Mar 2018 |
| Q4 2017 | 6.75x | -5.23x | -44% | 31 Dec 2017 |
| Q3 2017 | 7.45x | -8.19x | -52% | 30 Sep 2017 |
| Q2 2017 | 8.52x | -11.68x | -58% | 30 Jun 2017 |
| Q1 2017 | 10.47x | -13.49x | -56% | 31 Mar 2017 |
| Q4 2016 | 11.98x | -13.99x | -54% | 31 Dec 2016 |
| Q3 2016 | 15.64x | -6.4x | -29% | 30 Sep 2016 |
| Q2 2016 | 20.2x | +1.12x | +5.9% | 30 Jun 2016 |
| Q1 2016 | 23.96x | +9.69x | +68% | 31 Mar 2016 |
| Q4 2015 | 25.98x | +9.67x | +59% | 31 Dec 2015 |
| Q3 2015 | 22.04x | +5.82x | +36% | 30 Sep 2015 |
| Q2 2015 | 19.08x | +2.28x | +14% | 30 Jun 2015 |
| Q1 2015 | 14.27x | -4.66x | -25% | 31 Mar 2015 |
| Q4 2014 | 16.31x | +0.57x | +3.6% | 31 Dec 2014 |
| Q3 2014 | 16.22x | -1.39x | -7.9% | 30 Sep 2014 |
| Q2 2014 | 16.8x | +2.53x | +18% | 30 Jun 2014 |
| Q1 2014 | 18.93x | +11.8x | +165% | 31 Mar 2014 |
| Q4 2013 | 15.74x | +7.22x | +85% | 31 Dec 2013 |
| Q3 2013 | 17.61x | +9.4x | +114% | 30 Sep 2013 |
| Q2 2013 | 14.27x | +6.16x | +76% | 30 Jun 2013 |
| Q1 2013 | 7.13x | -1.11x | -13% | 31 Mar 2013 |
| Q4 2012 | 8.52x | 31 Dec 2012 | ||
| Q3 2012 | 8.22x | 30 Sep 2012 | ||
| Q2 2012 | 8.11x | 30 Jun 2012 | ||
| Q1 2012 | 8.24x | 31 Mar 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.